Fisherman E W, Cohen G N
Ann Allergy. 1976 Nov;37(5):353-6.
The introduction of new anti-inflammatory chemicals derived from propionic acid raised the possibility that they would not cross-react with the aspirin-salicylate type of anti-inflammatory drugs (and this group's cross-reactant chemicals). Thic allergic patients who have low tolerance for aspirin or BHA-BHT if concomitant low tolerance for iodides is also present. Likewise, ibuprofen is poorly tolerated by iodide intolerant patients. However, ASA or BHA-BHT intolerant patients who are tolerant of iodides tolerate a single 400 mgm motrin challenge; chronic motrin usage awaits further study. This study indicates that motrin is tolerated in patients tolerant of iodides but who suffer with extrinsic, atopic, allergic diseases and also in normals.
源自丙酸的新型抗炎化学物质的引入增加了一种可能性,即它们不会与阿司匹林 - 水杨酸盐类抗炎药物(以及该组的交叉反应性化学物质)发生交叉反应。对于那些对阿司匹林或丁基羟基茴香醚 - 二丁基羟基甲苯耐受性低且同时对碘化物耐受性也低的过敏患者也是如此。同样,对碘化物不耐受的患者对布洛芬耐受性差。然而,对碘化物耐受但对阿司匹林或丁基羟基茴香醚 - 二丁基羟基甲苯不耐受的患者能够耐受单次400毫克布洛芬激发试验;布洛芬的长期使用有待进一步研究。这项研究表明,对碘化物耐受但患有外源性、特应性、过敏性疾病的患者以及正常人能够耐受布洛芬。